Adtralza 150mg/ml

Adtralza 150mg/ml is a medicine authorised by Swissmedic under authorisation number 68229. The authorisation holder is Leo Pharmaceutical Products Sarath Ltd.. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 February 2022 and the authorisation is valid without a time limit. ATC code D11AH07 places the medicine in the group Other dermatological preparations.

  • Dispensing category B
  • Authorisation number 68229
  • ATC D11AH07
  • Biotechnological medicines
Authorisation data
Authorisation number68229
NameAdtralza 150mg/ml
Full nameAdtralza 150mg/ml, Injektionslösung in einer Fertigspritze
Authorisation holderLeo Pharmaceutical Products Sarath Ltd.
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeD11AH07
First authorisation24 February 2022
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Adtralza 150mg/ml, Injektionslösung in einer FertigspritzeB24 February 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
14Fertigspritze(n)D11AH0707.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Adtralza 150mg/ml authorised in Switzerland?

Yes. Adtralza 150mg/ml is authorised by Swissmedic under authorisation number 68229, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Adtralza 150mg/ml have?

Adtralza 150mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Adtralza 150mg/ml?

The authorisation holder is Leo Pharmaceutical Products Sarath Ltd.. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com